{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:47:22Z","timestamp":1782960442900,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05156-0","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:45:13Z","timestamp":1778337913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of a Golgi apparatus related gene signature for prognosis prediction and immune microenvironment profiling in colorectal cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Shuaiyi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"5156_CR1","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/cells12111499","volume":"12","author":"DB Vlad","year":"2023","unstructured":"Vlad DB, Dumitrascu DI, Dumitrascu AL. Golgi\u2019s role in the development of possible new therapies in cancer. Cells. 2023;12:1499. https:\/\/doi.org\/10.3390\/cells12111499.","journal-title":"Cells"},{"key":"5156_CR2","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14:101174. https:\/\/doi.org\/10.1016\/j.tranon.2021.101174.","journal-title":"Transl Oncol"},{"key":"5156_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683\u201391. https:\/\/doi.org\/10.1136\/gutjnl-2015-310912.","journal-title":"Gut"},{"key":"5156_CR4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"MS Hossain","year":"2022","unstructured":"Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, et al. Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel). 2022;14:1732. https:\/\/doi.org\/10.3390\/cancers14071732.","journal-title":"Cancers (Basel)"},{"key":"5156_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"5156_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.semcancer.2021.04.007","volume":"84","author":"P Andrei","year":"2022","unstructured":"Andrei P, Battuello P, Grasso G, Rovera E, Tesio N, Bardelli A. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better. Semin Cancer Biol. 2022;84:199\u2013213. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.007.","journal-title":"Semin Cancer Biol"},{"key":"5156_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/bios13100926","volume":"13","author":"SS Beniwal","year":"2023","unstructured":"Beniwal SS, Lamo P, Kaushik A, Lorenzo-Villegas DL, Liu Y, MohanaSundaram A. Current status and emerging trends in colorectal cancer screening and diagnostics. Biosens (Basel). 2023;13:926. https:\/\/doi.org\/10.3390\/bios13100926.","journal-title":"Biosens (Basel)"},{"key":"5156_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41392-022-01243-0","volume":"7","author":"J Yang","year":"2022","unstructured":"Yang J, Griffin A, Qiang Z, Ren J. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology. Signal Transduct Target Ther. 2022;7:379. https:\/\/doi.org\/10.1038\/s41392-022-01243-0.","journal-title":"Signal Transduct Target Ther"},{"key":"5156_CR9","doi-asserted-by":"publisher","first-page":"806482","DOI":"10.3389\/fcell.2021.806482","volume":"9","author":"S Bui","year":"2021","unstructured":"Bui S, Mejia I, D\u00edaz B, Wang Y. Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis. Front Cell Dev Biol. 2021;9:806482. https:\/\/doi.org\/10.3389\/fcell.2021.806482.","journal-title":"Front Cell Dev Biol"},{"key":"5156_CR10","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.7150\/jca.61567","volume":"12","author":"Y Dang","year":"2021","unstructured":"Dang Y, Yu J, Zhao S, Jin L, Cao X, Wang Q. GOLM1 Drives Colorectal Cancer Metastasis by Regulating Myeloid-derived Suppressor Cells. J Cancer. 2021;12:7158\u201366. https:\/\/doi.org\/10.7150\/jca.61567.","journal-title":"J Cancer"},{"key":"5156_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/ijms21030933","volume":"21","author":"S Sechi","year":"2020","unstructured":"Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R, Giansanti MG. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int J Mol Sci. 2020;21:933. https:\/\/doi.org\/10.3390\/ijms21030933.","journal-title":"Int J Mol Sci"},{"key":"5156_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1479-5876-12-15","volume":"12","author":"Z Wang","year":"2014","unstructured":"Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, et al. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy. J Transl Med. 2014;12:15. https:\/\/doi.org\/10.1186\/1479-5876-12-15.","journal-title":"J Transl Med"},{"key":"5156_CR13","doi-asserted-by":"publisher","first-page":"602174","DOI":"10.3389\/fcell.2020.602174","volume":"8","author":"J Xu","year":"2020","unstructured":"Xu J, Dai S, Yuan Y, Xiao Q, Ding K. A prognostic model for colon cancer patients based on eight signature autophagy genes. Front Cell Dev Biol. 2020;8:602174. https:\/\/doi.org\/10.3389\/fcell.2020.602174.","journal-title":"Front Cell Dev Biol"},{"key":"5156_CR14","doi-asserted-by":"publisher","first-page":"654076","DOI":"10.3389\/fonc.2021.654076","volume":"11","author":"J Nie","year":"2021","unstructured":"Nie J, Shan D, Li S, Zhang S, Zi X, Xing F, et al. A novel ferroptosis related gene signature for prognosis prediction in patients with colon cancer. Front Oncol. 2021;11:654076. https:\/\/doi.org\/10.3389\/fonc.2021.654076.","journal-title":"Front Oncol"},{"key":"5156_CR15","doi-asserted-by":"publisher","first-page":"e9847","DOI":"10.7717\/peerj.9847","volume":"8","author":"Y Miao","year":"2020","unstructured":"Miao Y, Li Q, Wang J, Quan W, Li C, Yang Y, et al. Prognostic implications of metabolism-associated gene signatures in colorectal cancer. PeerJ. 2020;8:e9847. https:\/\/doi.org\/10.7717\/peerj.9847.","journal-title":"PeerJ"},{"key":"5156_CR16","doi-asserted-by":"publisher","first-page":"755789","DOI":"10.3389\/fgene.2021.755789","volume":"12","author":"XT Lin","year":"2021","unstructured":"Lin XT, Wu QN, Qin S, Fan DJ, Lv MY, Chen X, et al. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer. Front Genet. 2021;12:755789. https:\/\/doi.org\/10.3389\/fgene.2021.755789.","journal-title":"Front Genet"},{"key":"5156_CR17","doi-asserted-by":"publisher","first-page":"31355","DOI":"10.1038\/s41598-024-82789-7","volume":"14","author":"R Ye","year":"2024","unstructured":"Ye R, Yuan Q, You W, Huang Y, Lin Z, Tang H, et al. Identification of the shared gene signatures in retinoblastoma and osteosarcoma by machine learning. Sci Rep. 2024;14:31355. https:\/\/doi.org\/10.1038\/s41598-024-82789-7.","journal-title":"Sci Rep"},{"key":"5156_CR18","doi-asserted-by":"publisher","first-page":"218388","DOI":"10.1016\/j.canlet.2026.218388","volume":"645","author":"Q Yuan","year":"2026","unstructured":"Yuan Q, Zhang H, Zhang N, Qian Y, Hong Z, Wan X, et al. BPHL promotes TNBC stemness by resolving R-loops via POLR2A lactylation inhibition and BARD1-mediated ubiquitination. Cancer Lett. 2026;645:218388. https:\/\/doi.org\/10.1016\/j.canlet.2026.218388.","journal-title":"Cancer Lett"},{"key":"5156_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41419-024-06817-0","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Mu L, Li Y, Mi Y, Hu Y, Li X, et al. Golgi dispersal in cancer stem cells promotes chemoresistance of colorectal cancer via the Golgi stress response. Cell Death Dis. 2024;15:417. https:\/\/doi.org\/10.1038\/s41419-024-06817-0.","journal-title":"Cell Death Dis"},{"key":"5156_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"5156_CR21","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1093\/bioinformatics\/btz229","volume":"35","author":"CS Groeneveld","year":"2019","unstructured":"Groeneveld CS, Chagas VS, Jones SJM, Robertson AG, Ponder BAJ, Meyer KB, et al. RTNsurvival: an R\/Bioconductor package for regulatory network survival analysis. Bioinformatics. 2019;35:4488\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz229.","journal-title":"Bioinformatics"},{"key":"5156_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7"},{"key":"5156_CR23","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"5156_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"key":"5156_CR25","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/s0140-6736(18)30789-x","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128\u201339. https:\/\/doi.org\/10.1016\/s0140-6736(18)30789-x.","journal-title":"Lancet"},{"key":"5156_CR26","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22:bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"key":"5156_CR27","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","journal-title":"Innov (Camb)"},{"key":"5156_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","volume":"15","author":"RV Iozzo","year":"2011","unstructured":"Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011;15:1013\u201331. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01236.x.","journal-title":"J Cell Mol Med"},{"key":"5156_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"key":"5156_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.hoc.2022.02.005","volume":"36","author":"P Dharwadkar","year":"2022","unstructured":"Dharwadkar P, Zaki TA, Murphy CC. Colorectal cancer in younger adults. Hematol Oncol Clin North Am. 2022;36:449\u201370. https:\/\/doi.org\/10.1016\/j.hoc.2022.02.005.","journal-title":"Hematol Oncol Clin North Am"},{"key":"5156_CR31","doi-asserted-by":"crossref","unstructured":"Vallis J, Wang PP. The role of diet and lifestyle in colorectal cancer incidence and survival. In Morgado-Diaz J A. Gastrointestinal Cancers. Brisbane (AU): Exon Publications, 2022.13\u201324.","DOI":"10.36255\/exon-publications-gastrointestinal-cancers-diet-colorectal-cancer"},{"key":"5156_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-015-0261-3","volume":"34","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhang M, Yu F, Lu S, Sun H, Tang H, et al. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer. J Exp Clin Cancer Res. 2015;34:145. https:\/\/doi.org\/10.1186\/s13046-015-0261-3.","journal-title":"J Exp Clin Cancer Res"},{"key":"5156_CR33","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3724\/abbs.2024107","volume":"56","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yi W, Zhu Q. Glycosylation in the tumor immune response: the bitter side of sweetness. Acta Biochim Biophys Sin (Shanghai). 2024;56:1184\u201398. https:\/\/doi.org\/10.3724\/abbs.2024107.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5156_CR34","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.7150\/ijbs.93806","volume":"20","author":"X Ren","year":"2024","unstructured":"Ren X, Lin S, Guan F, Kang H. Glycosylation targeting: A paradigm shift in cancer immunotherapy. Int J Biol Sci. 2024;20:2607\u201321. https:\/\/doi.org\/10.7150\/ijbs.93806.","journal-title":"Int J Biol Sci"},{"key":"5156_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/cells11091484","volume":"11","author":"R Bajaj","year":"2022","unstructured":"Bajaj R, Warner AN, Fradette JF, Gibbons DL. Dance of the Golgi: understanding Golgi dynamics in cancer metastasis. Cells. 2022;11:1484. https:\/\/doi.org\/10.3390\/cells11091484.","journal-title":"Cells"},{"key":"5156_CR36","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11010-024-04977-3","volume":"480","author":"H Gong","year":"2025","unstructured":"Gong H, Yang X, An L, Zhang W, Liu X, Shu L, et al. PCSK5 downregulation promotes the inhibitory effect of andrographolide on glioblastoma through regulating STAT3. Mol Cell Biochem. 2025;480:521\u201333. https:\/\/doi.org\/10.1007\/s11010-024-04977-3.","journal-title":"Mol Cell Biochem"},{"key":"5156_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12943-022-01667-w","volume":"21","author":"H Ji","year":"2022","unstructured":"Ji H, Kim TW, Lee WJ, Jeong SD, Cho YB, Kim HH. Two circPPFIA1s negatively regulate liver metastasis of colon cancer via miR-155-5p\/CDX1 and HuR\/RAB36. Mol Cancer. 2022;21:197. https:\/\/doi.org\/10.1186\/s12943-022-01667-w.","journal-title":"Mol Cancer"},{"key":"5156_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/cancers14010252","volume":"14","author":"J Drury","year":"2022","unstructured":"Drury J, Rychahou PG, Kelson CO, Geisen ME, Wu Y, He D, et al. Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression. Cancers (Basel). 2022;14:252. https:\/\/doi.org\/10.3390\/cancers14010252.","journal-title":"Cancers (Basel)"},{"key":"5156_CR39","doi-asserted-by":"publisher","first-page":"e70660","DOI":"10.1111\/jcmm.70660","volume":"29","author":"R Li","year":"2025","unstructured":"Li R, Wang X, Liu J, Cai Z, Li Z, Tao Q, et al. DPP7 Promotes Colorectal Cancer Progression Through GPX4-Dependent Suppression of Disulfidptosis and Immune Evasion. J Cell Mol Med. 2025;29:e70660. https:\/\/doi.org\/10.1111\/jcmm.70660.","journal-title":"J Cell Mol Med"},{"key":"5156_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41388-021-02116-6","volume":"41","author":"F Han","year":"2022","unstructured":"Han F, Zhang L, Liao S, Zhang Y, Qian L, Hou F, et al. The interaction between S100A2 and KPNA2 mediates NFYA nuclear import and is a novel therapeutic target for colorectal cancer metastasis. Oncogene. 2022;41:657\u201370. https:\/\/doi.org\/10.1038\/s41388-021-02116-6.","journal-title":"Oncogene"},{"key":"5156_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/0115665232325395241018103006","volume":"25","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang L, Li D, Gou M. Comprehensive analysis and experimental validation of HEPACAM2 as a potential prognosis biomarker and immunotherapy target in colorectal cancer. Curr Gene Ther. 2025;25:518\u201331. https:\/\/doi.org\/10.2174\/0115665232325395241018103006.","journal-title":"Curr Gene Ther"},{"key":"5156_CR42","doi-asserted-by":"publisher","first-page":"1407449","DOI":"10.3389\/fimmu.2024.1407449","volume":"15","author":"W Liu","year":"2024","unstructured":"Liu W, Kuang T, Liu L, Deng W. The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research. Front Immunol. 2024;15:1407449. https:\/\/doi.org\/10.3389\/fimmu.2024.1407449.","journal-title":"Front Immunol"},{"key":"5156_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.37349\/etat.2024.00212","volume":"5","author":"E Jou","year":"2024","unstructured":"Jou E, Chaudhury N, Nasim F. Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment. Explor Target Antitumor Ther. 2024;5:187\u2013207. https:\/\/doi.org\/10.37349\/etat.2024.00212.","journal-title":"Explor Target Antitumor Ther"},{"key":"5156_CR44","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"5156_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fimmu.2020.00369","volume":"11","author":"E Picard","year":"2020","unstructured":"Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Front Immunol. 2020;11:369. https:\/\/doi.org\/10.3389\/fimmu.2020.00369.","journal-title":"Front Immunol"},{"key":"5156_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/pgpm.S458798","volume":"17","author":"F Huang","year":"2024","unstructured":"Huang F, Wang Y, Shao Y, Zhang R, Li M, Liu L, et al. M2 macrophage classification of colorectal cancer reveals intrinsic connections with metabolism reprogramming and clinical characteristics. Pharmgenomics Pers Med. 2024;17:383\u201399. https:\/\/doi.org\/10.2147\/pgpm.S458798.","journal-title":"Pharmgenomics Pers Med"},{"key":"5156_CR47","doi-asserted-by":"publisher","first-page":"6305","DOI":"10.7150\/ijbs.117909","volume":"21","author":"J Chang","year":"2025","unstructured":"Chang J, Niu Y, Zhou S, Zhu W, Zhang Z, Xiu H, et al. DPP7 promotes fatty acid \u03b2-oxidation in tumor-associated macrophages and determines immunosuppressive microenvironment in colorectal cancer. Int J Biol Sci. 2025;21:6305\u201325. https:\/\/doi.org\/10.7150\/ijbs.117909.","journal-title":"Int J Biol Sci"},{"key":"5156_CR48","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.3390\/cancers12123717","volume":"12","author":"M Fuentes-Baile","year":"2020","unstructured":"Fuentes-Baile M, Ventero MP, Encinar JA, Garc\u00eda-Morales P, Poveda-Deltell M, P\u00e9rez-Valenciano E, et al. Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines. Cancers (Basel). 2020;12:3717. https:\/\/doi.org\/10.3390\/cancers12123717.","journal-title":"Cancers (Basel)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05156-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05156-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:35:54Z","timestamp":1782959754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05156-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5156"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05156-0","relation":{"references":[{"id-type":"doi","id":"10.1186\/1471-2105-14-7","asserted-by":"subject"}]},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study analysed de identified data from public databases (TCGA and GEO); therefore, no human or animal experiments were conducted, and ethical approval was not required. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"970"}}